Ophthalmology · Oakland, CA
NPI
1336132919
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3300 Telegraph Ave
Oakland, CA, 94609
Phone (510) 444-1600
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
14,556 services
Medicare patients, 2024
1,309
Average age 77
Drug cost, 2024
$45K
2,997 prescriptions
Company payments, 2025
$27.08
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eugene S Lit was code J2777 (injection, faricimab-svoa, 0.1 mg), 4,140 times for 14 patients. In total Eugene S Lit billed 14,556 services in 32 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 4,140 | 14 | $27.09 | $112K |
| 92134 Computerized Ophthalmic Imaging | Office | 3,277 | 1,127 | $36.56 | $120K |
| 67028 Intravitreal Injection | Office | 1,829 | 268 | $110.88 | $203K |
| 92012 Ophthalmological E&M | Office | 1,651 | 994 | $76.60 | $126K |
| J0178 Injection, aflibercept, 1 mg | Office | 1,412 | 84 | $650.93 | $919K |
| J7999 Compounded drug, not otherwise classified | Office | 1,269 | 189 | $71.67 | $91K |
| 99203 Office E&M - New | Office | 149 | 149 | $93.42 | $14K |
| 92235 Angiography | Office | 138 | 117 | $173.82 | $24K |
| 92250 Angiography | Office | 137 | 95 | $32.98 | $4,518 |
| 99214 Office E&M - Established | Office | 122 | 106 | $113.45 | $14K |
| 99204 Office E&M - New | Office | 79 | 79 | $131.02 | $10K |
| 76512 Ultrasound - Nonspecific | Office | 52 | 24 | $44.71 | $2,325 |
| J9035 Injection, bevacizumab, 10 mg | Office | 35 | 11 | $55.71 | $1,950 |
| 92083 Vision, Hearing, and Speech Services | Office | 23 | 18 | $62.93 | $1,447 |
| 67228 Eye | Office | 23 | 12 | $328.96 | $7,566 |
By year: 2022 $1.5M for 9,804 services; 2023 $1.5M for 10,403 services; 2024 $1.7M for 14,556 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eugene S Lit prescribed most often to Medicare patients was Ofloxacin, with 2,049 prescriptions and refills. In total Eugene S Lit wrote 2,997 Medicare prescriptions that cost $45K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ofloxacin Generic | 2,049 | 2,137 | 351 | $21K |
| Latanoprost Generic | 187 | 317 | 41 | $1,776 |
| Prednisolone Acetate Generic | 161 | 225 | 55 | $4,966 |
| Ciprofloxacin Hcl Generic | 152 | 157 | 59 | $1,463 |
| Timolol Maleate Generic | 109 | 182 | 28 | $831 |
| Ketorolac Tromethamine Generic | 102 | 107 | 34 | $1,192 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 37 | 105 | 15 | $597 |
| Brimonidine Tartrate Generic | 33 | 40 | 12 | $2,659 |
| Atropine Sulfate Generic | 30 | 53 | 12 | $697 |
| Dorzolamide Hcl Generic | 23 | 48 | Under 11 | $576 |
| Bromfenac Sodium Generic | 20 | 22 | Under 11 | $2,391 |
| Prednisone Generic | 17 | 19 | Under 11 | $144 |
| Polymyxin B Sul-Trimethoprim Polymyxin B Sulf/Trimethoprim | 16 | 25 | Under 11 | $75.74 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 15 | 16 | Under 11 | $127 |
| Loteprednol Etabonate Generic | 12 | 13 | Under 11 | $1,193 |
Brand drugs: 418 claims; generic drugs: 2,579 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eugene S Lit $27.08 ($27.08 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $27.08.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $27.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.